United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 2278,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "108455d8-c390-44df-8dbb-f57bf182e89e",
"title": "Upcoming Chicago Meeting for Guardant Health (GH) Investors | GH Stock News",
"description": "An important meeting concerning Guardant Health (GH) is scheduled to take place on June 2 in Chicago, organized by UBS. This event serves as a platform for inve",
"keywords": "GuruFocus, Article, News, GuruFocus News, GH",
"snippet": "An important meeting concerning Guardant Health (GH, Financial) is scheduled to take place on June 2 in Chicago, organized by UBS. This event serves as a platfo...",
"url": "https://www.gurufocus.com/news/2899418/upcoming-chicago-meeting-for-guardant-health-gh-investors-gh-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BIF0.png?20",
"language": "en",
"published_at": "2025-05-30T20:45:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GH",
"name": "Guardant Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 86.135445,
"sentiment_score": 0.278888,
"highlights": [
{
"highlight": "An important meeting concerning <em>Guar[+237 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "This meeting offers investors an opportu[+161 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+294 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+252 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+316 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Guardant</em> <em>H[+258 characters]",
"sentiment": 0.872,
"highlighted_in": "main_text"
},
{
"highlight": "Upcoming Chicago Meeting for <em>Guardant</em> <em>Health</em> (GH) Investors | GH Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "ea23eb07-05e8-4c47-b8f4-e6884ddf101c",
"title": "Guardant Health Inc (GH) Stock Price Up 5.11% on May 30",
"description": "Shares of Guardant Health Inc (GH) surged 5.11% in mid-day trading on May 30. The stock reached an intraday high of $41.05, before settling at $40.52, up fr",
"keywords": "GuruFocus, Article, News, GuruFocus News, GH",
"snippet": "Shares of Guardant Health Inc (GH, Financial) surged 5.11% in mid-day trading on May 30. The stock reached an intraday high of $41.05, before settling at $40.52...",
"url": "https://www.gurufocus.com/news/2899158/guardant-health-inc-gh-stock-price-up-511-on-may-30",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T18:10:56.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GH",
"name": "Guardant Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 128.59174,
"sentiment_score": 0.112067,
"highlights": [
{
"highlight": "Shares of <em>Guardant</em> <em>Health</[+286 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+294 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+251 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+181 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Guardant</em> <em>Health</em> <em>Inc</em> (GH) Stock Price Up 5.11% on May 30",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "GH.MX",
"name": "Guardant Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 128.58293,
"sentiment_score": 0.112067,
"highlights": [
{
"highlight": "Shares of <em>Guardant</em> <em>Health</[+286 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+294 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+251 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+181 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Guardant</em> <em>Health</em> <em>Inc</em> (GH) Stock Price Up 5.11% on May 30",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "0eb8532c-e8c2-45a4-8b47-19162b8cbdc6",
"title": "AbbVie (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News",
"description": "AbbVie (ABBV) has joined forces with the Chicago Cubs in a long-term collaboration aimed at raising cancer awareness. The initiative, named ”Striking Out Canc",
"keywords": "GuruFocus, Article, News, GuruFocus News, ABBV",
"snippet": "AbbVie (ABBV, Financial) has joined forces with the Chicago Cubs in a long-term collaboration aimed at raising cancer awareness. The initiative, named “Striki...",
"url": "https://www.gurufocus.com/news/2898354/abbvie-abbv-partners-with-chicago-cubs-for-cancer-awareness-initiative-abbv-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00009SSX.png?20",
"language": "en",
"published_at": "2025-05-30T13:30:55.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "4AB.DE",
"name": "AbbVie Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 50.190422,
"sentiment_score": -0.045656,
"highlights": [
{
"highlight": "<em>AbbVie</em> (ABBV, Financial) has jo[+221 characters]",
"sentiment": -0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the 2025 regular season, <em>[+246 characters]",
"sentiment": -0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+332 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AbbVie</em> <em>Inc[+303 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> <em>Inc</em> (ABBV) rais[+134 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "ABBV",
"name": "AbbVie Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 50.18883,
"sentiment_score": -0.045656,
"highlights": [
{
"highlight": "<em>AbbVie</em> (ABBV, Financial) has jo[+221 characters]",
"sentiment": -0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the 2025 regular season, <em>[+246 characters]",
"sentiment": -0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+332 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AbbVie</em> <em>Inc[+303 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> <em>Inc</em> (ABBV) rais[+134 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "ABBV.MX",
"name": "AbbVie Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 50.181213,
"sentiment_score": -0.045656,
"highlights": [
{
"highlight": "<em>AbbVie</em> (ABBV, Financial) has jo[+221 characters]",
"sentiment": -0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the 2025 regular season, <em>[+246 characters]",
"sentiment": -0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+332 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AbbVie</em> <em>Inc[+303 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> <em>Inc</em> (ABBV) rais[+134 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "ABBV34.SA",
"name": "AbbVie Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 50.178673,
"sentiment_score": -0.045656,
"highlights": [
{
"highlight": "<em>AbbVie</em> (ABBV, Financial) has jo[+221 characters]",
"sentiment": -0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the 2025 regular season, <em>[+246 characters]",
"sentiment": -0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+332 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AbbVie</em> <em>Inc[+303 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> <em>Inc</em> (ABBV) rais[+134 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "ABBV.BA",
"name": "AbbVie Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 50.176468,
"sentiment_score": -0.045656,
"highlights": [
{
"highlight": "<em>AbbVie</em> (ABBV, Financial) has jo[+221 characters]",
"sentiment": -0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the 2025 regular season, <em>[+246 characters]",
"sentiment": -0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+332 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AbbVie</em> <em>Inc[+303 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> <em>Inc</em> (ABBV) rais[+134 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "ABBVD.BA",
"name": "ABBVIE INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 50.176735,
"sentiment_score": -0.045656,
"highlights": [
{
"highlight": "<em>AbbVie</em> (ABBV, Financial) has jo[+221 characters]",
"sentiment": -0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the 2025 regular season, <em>[+246 characters]",
"sentiment": -0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+332 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AbbVie</em> <em>Inc[+303 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> <em>Inc</em> (ABBV) rais[+134 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "4905a93d-61d0-43e2-915f-a40757e2531a",
"title": "Goldman Sachs Asset Management Announces Final Liquidating Distribution of $0.291 Per Share for Goldman Sachs MLP and Energy Renaissance Fund",
"description": "NEW YORK —",
"keywords": "BW",
"snippet": "By signing up you consent to receive the above newsletter from Postmedia Network Inc.\n\nThanks for signing up!\n\nA welcome email is on its way. If you don't see i...",
"url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/goldman-sachs-asset-management-announces-final-liquidating-distribution-of-0-291-per-share-for-goldman-sachs-mlp-and-energy-renaissance-fund",
"image_url": "https://dcs-static.gprod.postmedia.digital/18.7.2/websites/images/fp/favicon-fp.ico",
"language": "en",
"published_at": "2025-05-30T20:37:13.000000Z",
"source": "financialpost.com",
"relevance_score": null,
"entities": [
{
"symbol": "GER",
"name": "Goldman Sachs MLP and Energy Renaissance Fund",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 252.48425,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "Goldman Sachs Asset Management Announces Final Liquidating Distribution of $0.291 Per Share for <em>Goldman</em> <em>Sachs</em> <em>MLP</em> <em>and</em> <em>Energy</em> <em>Renaissance</em> <em>Fund</em>",
"sentiment": 0.5719,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "4890e194-bbea-4ffe-bca4-fd82aa5c87e5",
"title": "AppLovin: Shedding Latency And Entering The High Throughput Phase",
"description": "Discover how AppLovin's 66% surge is fueled by AI-driven ad-tech innovation, strategic focus, and profitability. Click here to read my most recent analysis.",
"keywords": "",
"snippet": "I last covered AppLovin Corporation (NASDAQ: APP ) about 45 days ago, and dived into the company's expansion into ecommerce, and the massive TAM opportunity it ...",
"url": "https://seekingalpha.com/article/4791318-applovin-shedding-latency-and-entering-the-high-throughput-phase",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2096075337/image_2096075337.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-30T20:32:01.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "APP",
"name": "AppLovin Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 71.13752,
"sentiment_score": 0.21075,
"highlights": [
{
"highlight": "I last covered <em>AppLovin</em> <em>Cor[+288 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AppLovin</em>: Shedding Latency And Entering The High Throughput Phase",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "da885dc9-7864-404f-aa5b-a55c3f0ba504",
"title": "Beam Therapeutics (BEAM) Gains FDA Orphan Drug Status for Sickle Cell Treatment | BEAM Stock News",
"description": "Beam Therapeutics (BEAM) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting orphan drug designation to its investiga",
"keywords": "GuruFocus, Article, News, GuruFocus News, BEAM",
"snippet": "Beam Therapeutics (BEAM, Financial) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting orphan drug designation to it...",
"url": "https://www.gurufocus.com/news/2899416/beam-therapeutics-beam-gains-fda-orphan-drug-status-for-sickle-cell-treatment-beam-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BPMU.png?20",
"language": "en",
"published_at": "2025-05-30T20:30:14.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BEAM",
"name": "Beam Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 88.249664,
"sentiment_score": 0.3184,
"highlights": [
{
"highlight": "<em>Beam</em> <em>Therapeutics</em> (BEA[+190 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "This designation is intended to support [+271 characters]",
"sentiment": 0.9274,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+299 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+68 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Beam</em> <em>Therapeutics</em> (BEAM) Gains FDA Orphan Drug Status for Sickle Cell Treatment | BEAM Stock News",
"sentiment": 0.34,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "3999edb3-e8f1-4806-a530-2941e6dc152d",
"title": "KROS: Wedbush Reiterates Neutral Rating on Keros Therapeutics | KROS Stock News",
"description": "On May 30, 2025, analyst Yun Zhong from Wedbush reiterated a \"Neutral\" rating for Keros Therapeutics (KROS) stock. The rating remains unchanged compared to prio",
"keywords": "GuruFocus, Article, News, GuruFocus News, KROS",
"snippet": "On May 30, 2025, analyst Yun Zhong from Wedbush reiterated a \"Neutral\" rating for Keros Therapeutics (KROS, Financial) stock. The rating remains unchanged compa...",
"url": "https://www.gurufocus.com/news/2898690/kros-wedbush-reiterates-neutral-rating-on-keros-therapeutics-kros-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BSJH.png?20",
"language": "en",
"published_at": "2025-05-30T15:00:28.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "KROS",
"name": "Keros Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.554184,
"sentiment_score": -0.05464,
"highlights": [
{
"highlight": "On May 30, 2025, analyst Yun Zhong from [+329 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Investors should note that the analyst r[+159 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "KROS: Wedbush Reiterates Neutral Rating on <em>Keros</em> <em>Therapeutics</em> | KROS Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "00d015eb-6b59-45e9-9290-67f15a723682",
"title": "Viridian Therapeutics to Participate in Upcoming June Investor Conferences | VRDN Stock News",
"description": "Viridian Therapeutics (VRDN) to participate in Jefferies and Goldman Sachs Global Healthcare Conferences. Webcasts of the presentations will be availabl",
"keywords": "GuruFocus, Article, News, GuruFocus News, VRDN",
"snippet": "Viridian Therapeutics (VRDN, Financial) to participate in Jefferies and Goldman Sachs Global Healthcare Conferences.\n\nWebcasts of the presentations will be avai...",
"url": "https://www.gurufocus.com/news/2898094/viridian-therapeutics-to-participate-in-upcoming-june-investor-conferences-vrdn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AN0B.png?20",
"language": "en",
"published_at": "2025-05-30T12:17:59.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0K1R.L",
"name": "Viridian Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 85.65508,
"sentiment_score": 0.0417,
"highlights": [
{
"highlight": "<em>Viridian</em> <em>Therapeutics</em> [+350 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "As of recent, <em>Viridian</em> <em>Ther[+198 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Viridian</em> <em>Therapeutics</em> to Participate in Upcoming June Investor Conferences | VRDN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "VRDN",
"name": "Viridian Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.633354,
"sentiment_score": 0.0417,
"highlights": [
{
"highlight": "<em>Viridian</em> <em>Therapeutics</em> [+350 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "As of recent, <em>Viridian</em> <em>Ther[+198 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Viridian</em> <em>Therapeutics</em> to Participate in Upcoming June Investor Conferences | VRDN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "eca5b373-67c8-4298-933f-7691c4e40c43",
"title": "Summit Therapeutics (SMMT) Surges Following HARMONi Trial Results | SMMT Stock News",
"description": "Summit Therapeutics, with the ticker SMMT, saw a significant rise of 13% in its stock price, reaching $29.79. This jump came after the company released promisin",
"keywords": "GuruFocus, Article, News, GuruFocus News, SMMT",
"snippet": "Summit Therapeutics, with the ticker SMMT, saw a significant rise of 13% in its stock price, reaching $29.79. This jump came after the company released promisin...",
"url": "https://www.gurufocus.com/news/2898036/summit-therapeutics-smmt-surges-following-harmoni-trial-results-smmt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000MNE.png?20",
"language": "en",
"published_at": "2025-05-30T12:01:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SMMT",
"name": "Summit Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 72.626434,
"sentiment_score": 0.14175,
"highlights": [
{
"highlight": "<em>Summit</em> <em>Therapeutics</em>, w[+313 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+289 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Summit</em> <em>Therapeutics</em> (SMMT) Surges Following HARMONi Trial Results | SMMT Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "13ea9de3-7233-42c0-8bf3-8a4e87eb2feb",
"title": "Amicus Therapeutics Inc (FOLD) Announces Participation in Upcoming Investor Conferences | FOLD stock news",
"description": "Summary Amicus Therapeutics Inc (FOLD), a global biotechnology company dedicated to developing innovative medicines for rare diseases, announced on May 30, 2025",
"keywords": "GuruFocus, Article, News, GuruFocus News, FOLD",
"snippet": "Summary\n\nAmicus Therapeutics Inc (FOLD, Financial), a global biotechnology company dedicated to developing innovative medicines for rare diseases, announced on ...",
"url": "https://www.gurufocus.com/news/2898033/amicus-therapeutics-inc-fold-announces-participation-in-upcoming-investor-conferences-fold-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T12:01:00.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "FOLD",
"name": "Amicus Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 125.33801,
"sentiment_score": 0.509414,
"highlights": [
{
"highlight": "Summary\n\n<em>Amicus</em> <em>Therapeutic[+245 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Live audio webcasts of these presentatio[+319 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+281 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: When and where will <em>Amicus</[+341 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: The live audio webcasts can be access[+248 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Amicus</em> <em>Therapeutics</em> <em>Inc</em> (FOLD) Announces Participation in Upcoming Investor Conferences | FOLD stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "FOLD.MX",
"name": "Amicus Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 125.36324,
"sentiment_score": 0.509414,
"highlights": [
{
"highlight": "Summary\n\n<em>Amicus</em> <em>Therapeutic[+245 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Live audio webcasts of these presentatio[+319 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+281 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: When and where will <em>Amicus</[+341 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: The live audio webcasts can be access[+248 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Amicus</em> <em>Therapeutics</em> <em>Inc</em> (FOLD) Announces Participation in Upcoming Investor Conferences | FOLD stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HF9.L",
"name": "Amicus Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 125.357574,
"sentiment_score": 0.509414,
"highlights": [
{
"highlight": "Summary\n\n<em>Amicus</em> <em>Therapeutic[+245 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Live audio webcasts of these presentatio[+319 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+281 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: When and where will <em>Amicus</[+341 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: The live audio webcasts can be access[+248 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Amicus</em> <em>Therapeutics</em> <em>Inc</em> (FOLD) Announces Participation in Upcoming Investor Conferences | FOLD stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "16c50255-4082-4afd-8bab-748733fb1325",
"title": "Palantir Rallies on AI Deal With Fannie Mae to Fight Mortgage Fraud",
"description": "Palantir Technologies (PLTR, Financials) said Wednesday it's partnering with Fannie Mae to use artificial intelligence to detect mortgage fraud””slashing inves",
"keywords": "GuruFocus, Article, News, Faizan Farooque, PLTR",
"snippet": "Palantir Technologies (PLTR, Financials) said Wednesday it's partnering with Fannie Mae to use artificial intelligence to detect mortgage fraud—slashing inves...",
"url": "https://www.gurufocus.com/news/2899365/palantir-rallies-on-ai-deal-with-fannie-mae-to-fight-mortgage-fraud",
"image_url": "https://static.gurufocus.com/1651707455731662848.jpg",
"language": "en",
"published_at": "2025-05-30T20:25:57.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "FMCC",
"name": "Freddie Mac",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 42.53128,
"sentiment_score": -0.34,
"highlights": [
{
"highlight": "William Pulte, head of the Federal Housi[+320 characters]",
"sentiment": -0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "FMCKL",
"name": "Freddie Mac",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 42.53108,
"sentiment_score": -0.34,
"highlights": [
{
"highlight": "William Pulte, head of the Federal Housi[+320 characters]",
"sentiment": -0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "FMCCI",
"name": "Freddie Mac",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 42.53108,
"sentiment_score": -0.34,
"highlights": [
{
"highlight": "William Pulte, head of the Federal Housi[+320 characters]",
"sentiment": -0.34,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "702a741f-706f-4692-bfbf-9f692fcab5ff",
"title": "Upstream Natural Gas Valuations: A Big Year",
"description": "Amid the uncertainty in oil markets, for the past year or so, optimism and valuation metrics for natural gas producers have steadily been rising.",
"keywords": "",
"snippet": "The electron precedes the molecule or so the saying goes. Well, that is not really an axiom to my knowledge, but it does seem to fit. Amid the uncertainty in oi...",
"url": "https://www.forbes.com/sites/bryceerickson1/2025/05/30/upstream-natural-gas-valuations-a-big-year/",
"image_url": "https://imageio.forbes.com/specials-images/imageserve/683a13269bcefade4178d610/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
"language": "en",
"published_at": "2025-05-30T20:21:34.000000Z",
"source": "forbes.com",
"relevance_score": null,
"entities": [
{
"symbol": "VST",
"name": "Vistra Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 17.113964,
"sentiment_score": 0.7964,
"highlights": [
{
"highlight": "Blackstone is acquiring TXNM Energy, NRG[+217 characters]",
"sentiment": 0.7964,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "c13b56ae-2969-4a66-87a1-5d7736440bd8",
"title": "Solo travelers pay more than groups for economy flights on major US airlines: report",
"description": "Solo travelers face higher airline ticket prices on major U.S. carriers compared to group travelers, with significant fare differences on domestic one-way flights.",
"keywords": "",
"snippet": "Solo and business-class travelers are paying more for airline tickets on major U.S. carriers than group travelers, according to a recent report.\n\nFlight deal an...",
"url": "https://www.foxbusiness.com/lifestyle/solo-travelers-pay-more-than-groups-economy-flights-major-us-airlines",
"image_url": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/09/0/0/a7bc47f8-2.jpg?ve=1&tl=1",
"language": "en",
"published_at": "2025-05-30T20:18:33.000000Z",
"source": "video.foxbusiness.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAL",
"name": "American Airlines Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 32.329956,
"sentiment_score": 0.66245,
"highlights": [
{
"highlight": "Flight deal analysts at Thrifty Traveler[+207 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Ticker Security Last Change Change % AAL[+367 characters]",
"sentiment": 0.7125,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "UAL",
"name": "United Airlines Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 32.243385,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "Ticker Security Last Change Change % AAL[+349 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DAL",
"name": "Delta Air Lines, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 42.45182,
"sentiment_score": 0.554967,
"highlights": [
{
"highlight": "Flight deal analysts at Thrifty Traveler[+216 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Ticker Security Last Change Change % AAL[+349 characters]",
"sentiment": 0.7125,
"highlighted_in": "main_text"
},
{
"highlight": "Ticker Security Last Change Change % ALK[+300 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LUV",
"name": "Southwest Airlines Co.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 33.741806,
"sentiment_score": 0.5536,
"highlights": [
{
"highlight": "<em>SOUTHWEST</em> <em>AIRLINES</em> END[+270 characters]",
"sentiment": 0.7672,
"highlighted_in": "main_text"
},
{
"highlight": "Ticker Security Last Change Change % ALK[+300 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ALK",
"name": "Alaska Air Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 29.589378,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "Ticker Security Last Change Change % ALK[+309 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "a65ad760-59bb-4357-85b0-ff23968738ac",
"title": "Why Ulta’s Raised Guidance and Profitability Metrics Signal More Upside Ahead",
"description": "Market Analysis by covering: Amazon.com Inc, Ulta Beauty Inc. Read 's Market Analysis on Investing.com",
"keywords": "",
"snippet": "Ulta Beauty (NASDAQ: ) delivered a strong first-quarter earnings beat that exceeded Wall Street expectations, prompting multiple analyst price target increases ...",
"url": "https://www.investing.com/analysis/why-ultas-raised-guidance-and-profitability-metrics-signal-more-upside-ahead-200661543",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investingcom_analysis_og.jpg",
"language": "en",
"published_at": "2025-05-30T20:12:00.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ULTA",
"name": "Ulta Beauty, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 29.042183,
"sentiment_score": 0.828213,
"highlights": [
{
"highlight": "<em>Ulta</em> <em>Beauty</em> (NASDAQ: )[+282 characters]",
"sentiment": 0.8957,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ulta</em> <em>Beauty</em> Reports St[+275 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "Following the strong quarterly results, [+153 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Analyst Community Responds with Multiple[+326 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Under the leadership of new CEO Kecia St[+322 characters]",
"sentiment": 0.8979,
"highlighted_in": "main_text"
},
{
"highlight": "Ulta Beauty’s Shares Gain on Strong Ea[+208 characters]",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "Year-to-date, <em>Ulta</em> <em>Beauty</[+290 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ulta</em> <em>Beauty</em> maintains [+256 characters]",
"sentiment": 0.8689,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "5081d005-b6ad-4ce4-ae8f-2517736c155a",
"title": "Marvell: June Event Becomes The Moment Of Truth (NASDAQ:MRVL)",
"description": "Marvell Technology, Inc. shows good fundamentals with earnings recovery, but custom silicon uncertainty. Click for key insights ahead of June's critical MRVL event.",
"keywords": "",
"snippet": "I started covering Marvell Technology, Inc. (NASDAQ: MRVL ) on Seeking Alpha after their Q4 earnings. At that point, the stock had already taken a significant h...",
"url": "https://seekingalpha.com/article/4791314-marvell-june-event-becomes-the-moment-of-truth",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1291110254/image_1291110254.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-30T20:11:06.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRVL",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 89.32224,
"sentiment_score": 0.4378,
"highlights": [
{
"highlight": "I started covering <em>Marvell</em> <em>[+314 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Marvell: June Event Becomes The Moment Of Truth (<em>NASDAQ:MRVL</em>)",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "975c20c2-dd28-4190-bd90-a1a424e0e2bf",
"title": "Marvell Technology Inc (MRVL) Shares Down 7.59% on May 30",
"description": "Shares of Marvell Technology Inc (MRVL) fell 7.59% in mid-day trading on May 30. The stock reached an intraday low of $58.61, before recovering slightly to $5",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRVL",
"snippet": "Shares of Marvell Technology Inc (MRVL, Financial) fell 7.59% in mid-day trading on May 30. The stock reached an intraday low of $58.61, before recovering sligh...",
"url": "https://www.gurufocus.com/news/2899092/marvell-technology-inc-mrvl-shares-down-759-on-may-30",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T18:07:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRVL",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 128.62361,
"sentiment_score": 0.11455,
"highlights": [
{
"highlight": "Shares of <em>Marvell</em> <em>Technolog[+303 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+186 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Marvell</em> <em>Technology</em> <em>Inc</em> (MRVL) Shares Down 7.59% on May 30",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRVL1.MX",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 128.56961,
"sentiment_score": 0.11455,
"highlights": [
{
"highlight": "Shares of <em>Marvell</em> <em>Technolog[+303 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+186 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Marvell</em> <em>Technology</em> <em>Inc</em> (MRVL) Shares Down 7.59% on May 30",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "0UBI.L",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 128.56146,
"sentiment_score": 0.11455,
"highlights": [
{
"highlight": "Shares of <em>Marvell</em> <em>Technolog[+303 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+186 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Marvell</em> <em>Technology</em> <em>Inc</em> (MRVL) Shares Down 7.59% on May 30",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "0a6ce2d7-2495-4478-b7e1-23f8fa23e049",
"title": "MRVL Stock Update: Wells Fargo Adjusts Price Target for Marvell Tech | MRVL Stock News",
"description": "In recent developments, Wells Fargo analyst Aaron Rakers has made significant adjustments to the stock outlook of Marvell Tech (MRVL). The investment bank has m",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRVL",
"snippet": "In recent developments, Wells Fargo analyst Aaron Rakers has made significant adjustments to the stock outlook of Marvell Tech (MRVL, Financial). The investment...",
"url": "https://www.gurufocus.com/news/2898746/mrvl-stock-update-wells-fargo-adjusts-price-target-for-marvell-tech-mrvl-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000088Q.png?20",
"language": "en",
"published_at": "2025-05-30T15:30:13.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRVL",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 56.13155,
"sentiment_score": 0.1361,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+69 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRVL1.MX",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 51.596912,
"sentiment_score": 0.1361,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+69 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0UBI.L",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 51.610256,
"sentiment_score": 0.1361,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+69 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "a5ab9b1b-26ef-4e7b-afe2-447ba81bfaf4",
"title": "Behind the Scenes of Coinbase Global's Latest Options Trends - Coinbase Global (NASDAQ:COIN)",
"description": "",
"keywords": "",
"snippet": "Financial giants have made a conspicuous bearish move on Coinbase Global. Our analysis of options history for Coinbase Global COIN revealed 53 unusual trades.\n\n...",
"url": "https://www.benzinga.com/insights/options/25/05/45704211/behind-the-scenes-of-coinbase-globals-latest-options-trends",
"image_url": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
"language": "en",
"published_at": "2025-05-30T20:10:52.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "COIN",
"name": "Coinbase Global, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 87.97959,
"sentiment_score": 0.1834,
"highlights": [
{
"highlight": "Financial giants have made a conspicuous[+265 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Latest Startup Investment Opportunities:[+234 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Coinbase</em> <em>Global</em> Call a[+103 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Date Ask Bid Price Strike Price Total Tr[+347 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "$148.8K 7 30 <em>COIN</em> CALL SWEEP BE[+195 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "In light of the recent options history f[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Professional Analyst Ratings for <em>Coi[+293 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Click here for access. * An analyst from[+346 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "a Outperform rating for <em>Coinbase</em[+356 characters]",
"sentiment": 0.368,
"highlighted_in": "main_text"
},
{
"highlight": "Stay informed about the latest <em>Coinb[+80 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Behind the Scenes of Coinbase Global's Latest Options Trends - <em>Coinbase</em> <em>Global</em> (<em>NASDAQ:COIN</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 3291,
"sentiment_avg": 0.2962693880417769
}
]
}
Other details
Entity count
- 32,649